STIM:NASDAQ
Neuronetics Inc
$2.14
arrow_downward
-1.38%(-0.030) 1D
$2.12
arrow_downward
-0.93% (-0.020)bedtimeAfter hours
Closed: Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$2.19
High
$2.19
Low
$2.10
Mkt. cap
163.06M
Avg. vol.
1.15M
Volume
646.88K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
Open
$2.19
High
$2.19
Low
$2.10
Mkt. cap
163.06M
Avg. vol.
1.15M
Volume
646.88K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
News stories
From web sources and news partners
MarketBeat
·
22 minutes ago
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 6,444 Shares of Company Stock
The Globe and Mail
·
30 minutes ago
History Says Every S&P 500 Bull Market That Reached Its 4th Birthday Kept Going
Yahoo Finance
·
42 minutes ago
Nasdaq 100 Ends Lower As Report Of Weaker-Than-Expected OpenAI Revenue Drags Chipmakers — NVDA, DIS, ORCL, SBUX In Focus
Investor's Business Daily
·
2 hours ago
Futures: AI Stocks Skid On OpenAI; SpaceX Move Hits Telecom Rivals
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Websiteneurostar.com